Vimarsana
Biggest News Aggregation in the World

Selectively Target News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Selectively Target. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Selectively Target Today - Breaking & Trending Today

New molecular flypaper can detect or inactivate viruses, bacteria, and other pathogens - Vimarsana News

New molecular flypaper can detect or inactivate viruses, bacteria, and other pathogens

The nanosheets could also potentially be used in environmental cleanups to neutralize specific toxins and pathogens, and the sheets could potentially be scaled to target viruses like Ebola and bacteria like E. coli, and other pathogens

This Small Cap Stock Surged Over 100% - Vimarsana News

This Small Cap Stock Surged Over 100%

Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (NASDAQ:ELOX) rocketed almost 100% yesterday

Why Eloxx Pharmaceuticals (ELOX) Stock Is Soaring Tuesday - Eloxx Pharmaceuticals (NASDAQ:ELOX) - Vimarsana News

Why Eloxx Pharmaceuticals (ELOX) Stock Is Soaring Tuesday - Eloxx Pharmaceuticals (NASDAQ:ELOX)

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55.

Eloxx Pharmaceuticals Stock Surges 110% - Vimarsana News

Eloxx Pharmaceuticals Stock Surges 110%

Shares of Eloxx Pharmaceuticals, Inc. (ELOX) are surging over 110% on Tuesday morning after its price target was raised by analysts at Oppenheimer Holdings Inc. from $50.

Eloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit - Vimarsana News

Eloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit

Publication titled “A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal…